Thursday, 8 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Gennex Laboratories Ltd

NSE: GENNEX · BSE: 531739 · Pharmaceuticals & Biotechnology · 18 announcements

Share price
₹9.97
Market cap
₹242.2 Cr
Revenue (annual)
₹172.7 Cr
Net profit (annual)
₹20.98 Cr
P/E (TTM)
10.2×Sector 47.3×
Promoter holding
23.63%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

17:25 IST BSE
Board Meeting Outcome

Gennex Laboratories Board Meeting Outcome

Gennex Laboratories announced the outcome of its board meeting, approving the draft directors' report and scheduling the 41st Annual General Meeting for September 30, 2026.

15:29 IST BSE
Board Meeting Outcome

Gennex Laboratories Board Meeting Outcome

Gennex Laboratories Limited has scheduled a Board Meeting on April 16, 2026. The board will discuss the conduct of an Extraordinary General Meeting (EGM) for the regularization of Ms. Khushbu Kachhawa as an Independent Woman Director and the appointment of a scrutinizer for the meeting.